Study guide
16.3 Critical Limb Ischemia & Acute Arterial Occlusion
ABFM Family Medicine Certification Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Blueprint & Clinical Decision-Making
1.1 Exam Blueprint, FMCLA vs. One-Day Exam & Board Scoring 1.2 Clinical Reasoning, Test-Taking Strategy & Ambiguity Management 1.3 Evidence-Based Medicine & Clinical Practice Guidelines in Primary Care
2 Chapter 2: Healthcare Systems, Practice Management & Quality
2.1 Practice Management, Billing, Coding & Documentation 2.2 Quality Improvement, Patient Safety & Diagnostic Stewardship 2.3 Interprofessional Team-Based Care & Care Coordination
3 Chapter 3: Ethics, Law, Biostatistics & Health Equity
3.1 Medical Ethics, Informed Consent & Surrogate Decision-Making 3.2 Biostatistics, Clinical Epidemiology & Diagnostic Test Interpretation 3.3 Social Determinants of Health, Health Equity & Cultural Humility 3.4 Physician Wellness, Burnout Prevention & Professionalism
4 Chapter 4: Lifestyle Counseling & Behavior Change
4.1 Alcohol Use Screening & Brief Intervention 4.2 Illicit Drug & Cannabis Counseling 4.3 Tobacco & Vaping Cessation Counseling
5 Chapter 5: Nutrition, Physical Activity & Chronic Disease Prevention
5.1 Dietary Counseling for Obesity & Chronic Disease Prevention 5.2 Exercise Prescription & Physical Activity Counseling 5.3 Genetic Risk Assessment & Family History Counseling
6 Chapter 6: Routine Adult Immunizations
6.1 ACIP Adult Respiratory Vaccines: Influenza, COVID-19, RSV & Pneumococcal 6.2 ACIP Adult Non-Respiratory Vaccines: Tdap, Shingrix, HPV & Hep B 6.3 Immunizations in Special Populations: Pregnancy, Asplenia & Immunocompromise
7 Chapter 7: Pediatric Health Maintenance & Surveillance
7.1 Newborn Examination & Early Postnatal Care 7.2 Well-Child Care, Developmental Surveillance & Milestones 7.3 Pediatric & Adolescent Screening: Vision, Hearing, Anemia & Lead 7.4 Pediatric Oral Health, Dental Screening & Fluoride
8 Chapter 8: Behavioral Health & Safety Screening
8.1 Primary Care Depression, Anxiety & Behavioral Health Screening 8.2 Domestic Violence, Intimate Partner Violence & Firearm Safety 8.3 Occupational Health & Recreational Safety Counseling
9 Chapter 9: Adult Preventive Screening: Cardiovascular & Metabolic
9.1 Cardiovascular Disease & Hypertension Screening 9.2 Type 2 Diabetes Screening & Prediabetes Risk Stratification 9.3 Abdominal Aortic Aneurysm & Osteoporosis Screening
10 Chapter 10: Adult Cancer Screening: Breast & Gynecologic
10.1 Breast Cancer Screening & Risk-Assessment 10.2 Cervical Cancer Screening & ASCCP Algorithms 10.3 Skin Cancer Clinical Assessment & Counseling
11 Chapter 11: Adult Cancer Screening: Colorectal, Lung & Prostate
11.1 Colorectal Cancer Screening Modalities & Intervals 11.2 Lung Cancer Screening with Low-Dose CT 11.3 Prostate Cancer Screening & Shared Decision-Making
12 Chapter 12: Sexual Health, Infectious Disease Screening & Contraception
12.1 Sexual Health Counseling & Risk-Reduction Strategies 12.2 STI Screening: Chlamydia, Gonorrhea, Syphilis & Trichomoniasis 12.3 Bloodborne Infectious Disease Screening: HIV & Hepatitis C
13 Chapter 13: Reproductive Life Planning, Lactation & Preoperative Care
13.1 Preconception Planning & Comprehensive Contraception Management 13.2 Lactation Support & Breastfeeding Counseling 13.3 Preoperative Medical Evaluation & Pre-Participation Sports Exam
14 Chapter 14: Emergent Cardiovascular Conditions
14.1 Acute Coronary Syndromes & Myocardial Infarction 14.2 Acute Chest Pain Risk Stratification & Triage 14.3 Acute or Critical Valvular Heart Emergencies
15 Chapter 15: Cardiac Arrhythmias, Heart Failure & Hypertensive Crises
15.1 Acute Atrial & Ventricular Arrhythmias 15.2 Acute Decompensated Heart Failure & Cardiogenic Shock 15.3 Hypertensive Emergency & Urgency Management
16 Chapter 16: Vascular & Thromboembolic Emergencies
16.1 Pulmonary Embolism & Deep Vein Thrombosis 16.2 Acute Aortic Syndromes & Peripheral Vascular Emergencies 16.3 Critical Limb Ischemia & Acute Arterial Occlusion
17 Chapter 17: Neurologic Emergencies: Stroke & Altered Consciousness
17.1 Acute Ischemic Stroke & Intracranial Hemorrhage 17.2 Syncope Evaluation & Status Epilepticus 17.3 Acute Delirium, Encephalopathy & Severe Confusion
18 Chapter 18: Neurologic Trauma & Acute Cranial Emergencies
18.1 Concussion, Moderate-to-Severe TBI & Intracranial Injury 18.2 Thunderclap & Acute Severe Secondary Headaches 18.3 Acute Ophthalmologic Emergencies
19 Chapter 19: Acute Abdominal, Pelvic & Gastrointestinal Emergencies
19.1 Acute Abdominal & Pelvic Pain Triage 19.2 Upper & Lower Gastrointestinal Bleeding 19.3 Acute Hepatic Failure, Cholangitis & Severe Jaundice
20 Chapter 20: Acute Pulmonary & Airway Emergencies
20.1 Acute Hypoxic Respiratory Failure & ARDS 20.2 Severe Community-Acquired Pneumonia & Empyema 20.3 Acute Severe Epistaxis & Airway Obstruction
21 Chapter 21: Acute Traumatic Injuries & Wound Care
21.1 Major Trauma Resuscitation & Initial Assessment 21.2 Burn Assessment, Inhalation Injury & Resuscitation 21.3 Laceration Management, Complex Wounds & Animal Bites
22 Chapter 22: Acute Orthopedic & Musculoskeletal Emergencies
22.1 Acute Ambulatory Fractures & Initial Splinting 22.2 Compartment Syndrome & Major Orthopedic Trauma 22.3 Septic Arthritis & Acute Microcrystalline Crises
23 Chapter 23: Severe Infections, Sepsis & Systemic Emergencies
23.1 Sepsis, Septic Shock & Initial Fluid Resuscitation 23.2 Necrotizing Soft Tissue Infections & Severe CNS Infections 23.3 Anaphylaxis Diagnosis, Epinephrine Dosing & Airway Protection
24 Chapter 24: Metabolic, Endocrine & Electrolyte Emergencies
24.1 Diabetic Ketoacidosis & Hyperosmolar Hyperglycemic State 24.2 Critical Electrolyte Emergencies: Dyskalemias & Dysnatremias 24.3 Severe Calcium Abnormalities & Acute Adrenal Crisis
25 Chapter 25: Hematologic, Urologic & Dental Emergencies
25.1 Severe Symptomatic Anemias & Coagulopathic Emergencies 25.2 Testicular Torsion, Priapism & Acute Urinary Retention 25.3 Urgent Odontogenic Infections & Dental Trauma
26 Chapter 26: Psychiatric, Behavioral & Obstetric/Gynecologic Emergencies
26.1 Suicidal Ideation, Acute Agitation & Behavioral Emergencies 26.2 Acute Physical & Sexual Assault Care 26.3 Life-Threatening Vaginal Bleeding & Ectopic Pregnancy 26.4 Environmental Heat Stroke & Severe Hypothermia
27 Chapter 27: Acute Head, Neck & Neurologic Symptoms
27.1 Primary Acute Headaches: Migraine, Tension & Cluster 27.2 Concussion & Minor Closed Head Injury Evaluation 27.3 Transient Ischemic Attack Evaluation & ABCD2 Risk Scoring
28 Chapter 28: Acute Cranial Nerves, Hearing & Sensory Symptoms
28.1 Peripheral Neuropathies: Bell's Palsy, Carpal Tunnel & Radiculopathy 28.2 Acute Tinnitus, Sudden Sensorineural Hearing Loss & Cerumen Impaction 28.3 Acute Dizziness, Benign Paroxysmal Positional Vertigo & Vestibular Neuritis
29 Chapter 29: Acute Upper Respiratory Tract Infections
29.1 Acute Viral Rhinosinusitis vs. Bacterial Rhinosinusitis 29.2 Acute Pharyngitis: Group A Streptococcus & Centor Criteria 29.3 Acute Otitis Media, Otitis Externa & Serous Effusion
30 Chapter 30: Acute Lower Respiratory Infections & Cough
30.1 Influenza, COVID-19 & Viral Respiratory Syndromes 30.2 Acute Bronchitis & Lower Respiratory Tract Infections 30.3 Ambulatory Community-Acquired Pneumonia
31 Chapter 31: Allergic, Nasal & Non-Infectious Pulmonary Conditions
31.1 Allergic Rhinitis & Acute Non-Anaphylactic Allergic Reactions 31.2 Acute Dyspnea in Ambulatory Care 31.3 Interstitial Lung Diseases & Sarcoidosis Presentation
32 Chapter 32: Acute Chest, Cardiac & Vascular Symptoms
32.1 Palpitations Evaluation & Arrhythmia Triage in Primary Care 32.2 Deep Vein Thrombosis & Superficial Thrombophlebitis 32.3 Ambulatory Hypotension & Orthostasis Evaluation
33 Chapter 33: Acute Upper Gastrointestinal Conditions
33.1 Peptic Ulcer Disease & Gastritis 33.2 Dysphagia, Esophagitis & Acute Esophageal Disorders 33.3 Acute Nausea, Vomiting & Foodborne Illness
34 Chapter 34: Acute Lower Gastrointestinal Conditions
34.1 Acute Infectious Diarrhea & Gastroenteritis 34.2 Acute Constipation & Functional Bowel Changes 34.3 Ano-Rectal Disorders: Hemorrhoids, Fissures, Abscesses & Pruritus Ani
35 Chapter 35: Inflammatory, Functional & Malabsorptive GI Disorders
35.1 Acute Flares of Inflammatory Bowel Disease 35.2 Irritable Bowel Syndrome: Diagnosis, Subtyping & Management 35.3 Celiac Disease & Malabsorption Syndromes
36 Chapter 36: Acute Abdominal, Hepatic & Biliary Disorders
36.1 Ambulatory Abdominal & Pelvic Pain Triage 36.2 Acute Cholecystitis, Biliary Colic & Pancreatitis 36.3 Acute Liver Injury & Viral Hepatitis
37 Chapter 37: Acute Abdominal Wall, Hernias & Dental Conditions
37.1 Abdominal Wall, Inguinal & Ventral Hernias 37.2 Acute Dental Pain, Odontogenic Abscess & Aphthous Ulcers 37.3 Acute Edema: Unilateral vs. Bilateral Diagnostic Evaluation
38 Chapter 38: Acute Infectious Dermatoses
38.1 Bacterial Skin Infections: Impetigo, Cellulitis & Cutaneous Abscesses 38.2 Fungal Skin Infections: Tinea Corporis, Cruris, Pedis & Onychomycosis 38.3 Viral Cutaneous Infections: Herpes Simplex, Zoster & Molluscum Contagiosum
39 Chapter 39: Inflammatory, Allergic & Autoimmune Dermatoses
39.1 Atopic Dermatitis, Contact Dermatitis & Eczematous Flares 39.2 Non-Infectious Rashes: Urticaria, Drug Eruptions & Erythema Multiforme 39.3 Cutaneous Malignancies & Premalignant Lesions: AK, BCC, SCC & Melanoma
40 Chapter 40: Acute Shoulder, Elbow & Upper Extremity Injuries
40.1 Rotator Cuff Pathology, Tendinopathy & Shoulder Impingement 40.2 Lateral & Medial Epicondylitis, Olecranon Bursitis & Elbow Sprains 40.3 Wrist & Hand Soft-Tissue Injuries: De Quervain, TFCC & Finger Sprains
41 Chapter 41: Acute Knee, Ankle & Lower Extremity Injuries
41.1 Meniscal Tears, Ligamentous Knee Injuries & Patellofemoral Pain 41.2 Ankle Sprains, Ottawa Ankle Rules & Achilles Tendinopathy 41.3 Plantar Fasciitis, Shin Splints & Overuse Syndromes
42 Chapter 42: Acute Ambulatory Fractures & Dislocations
42.1 Distal Radius, Scaphoid & Common Upper Extremity Fractures 42.2 Metatarsal, Clavicle & Common Lower Extremity Fractures 42.3 Joint Dislocation Management: Nursemaid's Elbow & Shoulder Subluxation
43 Chapter 43: Acute Axial Musculoskeletal Pain & Falls
43.1 Acute Low Back Pain: Red Flags, Strain & Disc Herniation 43.2 Acute Cervical Strain, Whiplash & Axial Neck Pain 43.3 Evaluation of Falls in Ambulatory & Older Patients
44 Chapter 44: Acute Inflammatory Arthropathies & Generalized Pain
44.1 Acute Inflammatory Arthritis & Spondyloarthropathies 44.2 Myalgias, Rhabdomyolysis & Post-Viral Pain Syndromes 44.3 Acute Non-Headache Pain Management Strategies
45 Chapter 45: Acute Renal, Urinary & Genitourinary Conditions
45.1 Uncomplicated UTI, Pyelonephritis & Acute Urethritis 45.2 Hematuria Workup & Glomerulonephritis 45.3 Nephrolithiasis & Acute Urinary Tract Obstruction
46 Chapter 46: Acute Male Genitourinary & Prostatic Conditions
46.1 Acute Prostatitis, Epididymitis & Orchitis 46.2 Acute Scrotal Pain: Torsion vs Appendage, BPH & Male Genital Emergencies 46.3 Acute Urinary Retention & Incontinence Evaluation
47 Chapter 47: Acute Women's Health & Early Pregnancy Care
47.1 Early Pregnancy Diagnosis, Dating & Initial Complications 47.2 Abnormal Uterine Bleeding & Acute Menstrual Disorders 47.3 Premenstrual Syndrome & Premenstrual Dysphoric Disorder
48 Chapter 48: Breast Disorders, STIs & Pediatric Elimination
48.1 Palpable Breast Mass, Mastitis & Nipple Discharge 48.2 Sexually Transmitted Infections: Diagnosis, Staging & CDC Guidelines 48.3 Pediatric Enuresis & Encopresis
49 Chapter 49: Systemic Signs, Metabolic Dysregulation & Miscellaneous Infections
49.1 Acute Fever, Sepsis Screening & FUO in Primary Care 49.2 Acute Hyperglycemia & Symptomatic Hypoglycemia 49.3 Electrolyte Abnormalities: Mild-to-Moderate Disturbances 49.4 Vector-Borne, Tick-Borne & Rickettsial Illnesses
50 Chapter 50: Chronic Cardiovascular Diseases: Hypertension & Ischemia
50.1 Essential Hypertension Management: 2025 AHA/ACC Guideline & JNC Strategies 50.2 Chronic Coronary Artery Disease & Post-MI Secondary Prevention 50.3 Chronic Heart Failure: HFrEF, HFpEF & Quadruple GDMT
51 Chapter 51: Chronic Vascular, Valvular & Dyslipidemic Diseases
51.1 Peripheral Arterial Disease & Claudication 51.2 Chronic Valvular Heart Disease & Murmur Evaluation 51.3 Lipid Disorders & ASCVD Risk-Based Statin Therapy
52 Chapter 52: Chronic Respiratory Diseases: Asthma & COPD
52.1 Chronic Asthma Management: GINA Stepwise SMART Therapy 52.2 Chronic Obstructive Pulmonary Disease: GOLD Recommendations 52.3 Solitary Pulmonary Nodule Evaluation & Fleischner Society Criteria
53 Chapter 53: Chronic Metabolic Diseases: Diabetes Mellitus
53.1 Type 2 Diabetes Management: ADA Pharmacotherapy Algorithms 53.2 Type 1 Diabetes: Basal-Bolus Insulin, CGMs & Diabetic Complications 53.3 Diabetic Microvascular & Macrovascular Disease Surveillance
54 Chapter 54: Obesity, Nutrition & Metabolic Bone Diseases
54.1 Medical & Behavioral Management of Obesity & Incretin Mimetics 54.2 Osteoporosis & Metabolic Bone Disease: DEXA, FRAX & Antiresorptives 54.3 Nutritional Deficiencies: Vitamin D, B12, Iron & Malnutrition
55 Chapter 55: Chronic Endocrine Disorders
55.1 Primary & Subclinical Hypothyroidism, Hyperthyroidism & Nodules 55.2 Adrenal Disorders: Addison's Disease & Cushing's Syndrome 55.3 Hypercalcemia, Hyperparathyroidism & Pituitary Disorders
56 Chapter 56: Chronic Kidney Disease & Venous Disorders
56.1 Chronic Kidney Disease: KDIGO Staging & Renoprotective Therapy 56.2 Chronic Venous Insufficiency, Stasis Dermatitis & Lymphedema 56.3 Chronic Electrolyte & Acid-Base Management in CKD
57 Chapter 57: Chronic Gastrointestinal & Hepatic Diseases
57.1 Gastroesophageal Reflux Disease, Barrett's Esophagus & Dyspepsia 57.2 Chronic Liver Disease: MASLD/NAFLD, Cirrhosis & Portal Hypertension 57.3 Viral Hepatitis B & C: Long-Term Monitoring & DAA Therapy
58 Chapter 58: Colorectal Surveillance & Chronic Pancreaticobiliary Care
58.1 Post-Polypectomy Colorectal Polyp Surveillance Guidelines 58.2 Chronic Pancreatitis & Exocrine Pancreatic Insufficiency 58.3 Chronic Nausea, Gastroparesis & Functional GI Disorders
59 Chapter 59: Chronic Musculoskeletal & Rheumatologic Disorders
59.1 Osteoarthritis: Hip, Knee & Hand Management 59.2 Spinal Conditions: Spinal Stenosis, Spondylolisthesis & Compression Fractures 59.3 Chronic Myopathies & Fibromyalgia Syndrome
60 Chapter 60: Chronic Neurologic & Neurodegenerative Disorders
60.1 Dementia: Alzheimer's, Vascular & Lewy Body Disease 60.2 Parkinson's Disease & Essential Tremor 60.3 Epilepsy: Chronic Antiseizure Medications & Post-Stroke Care
61 Chapter 61: Chronic Peripheral Nerves, Pain & Sensory Disorders
61.1 Diabetic & Chronic Peripheral Neuropathies 61.2 Chronic Pain Syndromes & Chronic Daily Headaches 61.3 Chronic Tinnitus, Presbycusis & Persistent Dizziness
62 Chapter 62: Chronic Psychiatric Disorders
62.1 Major Depressive Disorder & Generalized Anxiety Disorder 62.2 Bipolar Disorder: Maintenance Pharmacotherapy & Lithium Monitoring 62.3 Adult & Pediatric Attention-Deficit/Hyperactivity Disorder
63 Chapter 63: Chronic Behavioral Health & Neurodevelopmental Conditions
63.1 Chronic Behavioral Conditions: PTSD, OCD & Somatization 63.2 Autism Spectrum Disorder & Intellectual Disabilities 63.3 Eating Disorders: Anorexia Nervosa, Bulimia & Binge Eating
64 Chapter 64: Chronic Substance Use Disorders & Tobacco Cessation
64.1 Alcohol Use Disorder: Pharmacotherapy & Relapse Prevention 64.2 Opioid & Stimulant Use Disorders: MOUD & Harm Reduction 64.3 Longitudinal Tobacco Cessation Pharmacotherapy
65 Chapter 65: Chronic Dermatologic Conditions
65.1 Acne Vulgaris, Rosacea & Seborrheic Dermatitis 65.2 Chronic Plaque Psoriasis & Biologic Therapies 65.3 Chronic Eczema, Hidradenitis Suppurativa & Cutaneous Lupus
66 Chapter 66: Chronic Reproductive, Infectious & Geriatric Special Care
66.1 Chronic Menstrual Disorders, Infertility & Sexual Dysfunction 66.2 Menopause Management & Hormone Replacement Therapy 66.3 Chronic HIV Infection Management & Primary Care Integration 66.4 Gender-Affirming Primary Care & Hormone Therapy 66.5 Advance Care Planning, Palliative Care & End-of-Life Symptom Control
67 Chapter 67: Continuity Care: Sleep, Fatigue, Cancer, Pregnancy & the Adult Preventive Visit
67.1 Chronic Insomnia & Obstructive Sleep Apnea 67.2 Chronic Malaise, Fatigue & ME/CFS 67.3 Primary Care During Cancer Treatment & Survivorship 67.4 Routine Prenatal Care & Longitudinal Pregnancy Management 67.5 The Periodic Adult Health Examination & Medicare Annual Wellness Visit
16.3 Critical Limb Ischemia & Acute Arterial Occlusion
Key Takeaways Explain This Topic AI
Acute limb ischemia (ALI) is a time-critical vascular emergency defined by a sudden decrease in limb perfusion threatening tissue viability, clinically heralded by the classic 6 P's: Pain, Pallor, Poikilothermia, Pulselessness, Paresthesias, and Paralysis.
Paresthesia is the earliest sensitive clinical indicator of peripheral nerve ischemia, whereas paralysis (motor loss, muscle rigor) signifies advanced, irreversible skeletal muscle necrosis and mandates immediate revascularization within 4 to 6 hours to prevent limb loss.
The Rutherford Clinical Classification categorizes ALI into Category I (viable, audible arterial Doppler), Category IIa (marginally threatened, minimal sensory loss, inaudible arterial Doppler), Category IIb (immediately threatened, motor deficit and rest pain, emergency revascularization), and Category III (irreversible, profound paralysis, rigor, inaudible arterial and venous Doppler, requiring primary amputation).
The immediate initial intervention upon clinical suspicion of ALI is systemic anticoagulation with an intravenous unfractionated heparin bolus (80 units/kg) followed by continuous infusion (18 units/kg/h) to prevent thrombus propagation and protect microvascular runoff.
Post-ischemic reperfusion risks acute compartment syndrome and reperfusion syndrome (rhabdomyolysis, hyperkalemia, acute kidney injury); intracompartmental pressures >30 mm Hg or Delta P ≤30 mm Hg mandate emergent 4-compartment lower leg fasciotomy.
Last updated: September 2026
Definition & Pathophysiology of Acute Limb Ischemia
Acute Limb Ischemia (ALI) is defined as a sudden, rapid decrease in lower or upper extremity arterial perfusion that threatens the viability of the affected limb, typically presenting within days to less than 2 weeks following symptom onset. ALI must be distinguished from Chronic Limb-Threatening Ischemia (CLTI) , which represents the end-stage progression of chronic peripheral artery disease (PAD) evolving over months with chronic ischemic rest pain, non-healing arterial ulcers, or gangrene.
Tissue Vulnerability & The Ischemic Time Window
Tissues within an extremity possess markedly disparate tolerances to warm ischemia:
Peripheral Nerves (Most Sensitive) : Peripheral sensory and motor nerves possess high metabolic demands. Functional neural impairment manifests within 15 to 30 minutes of complete arterial cessation. The loss of light touch, two-point discrimination, and vibratory sensation precedes motor deficits.
Skeletal Muscle : Skeletal muscle tissue can survive warm ischemia for approximately 4 to 6 hours . Beyond 6 hours of complete ischemia without arterial inflow, irreversible muscle cell membrane disruption, myocyte necrosis, intracellular edema, and fixed muscular contracture (rigor) inevitably develop.
Skin & Subcutaneous Tissue (Most Resilient) : Cutaneous and subcutaneous tissues can survive up to 12 to 24 hours of ischemia due to lower baseline metabolic requirements. Consequently, skin may appear viable even when underlying skeletal muscle compartments have already suffered irreversible necrosis.
The Classic "6 P's" of Acute Arterial Occlusion
The clinical syndrome of acute arterial occlusion is defined by the cardinal 6 P's , which reflect progressive neurovascular and muscular deprivation: THE 6 P'S OF ACUTE ARTERIAL OCCLUSION
- ┌───────────────┬─────────────────────────────────────────────────────────────┐
- │ 1. PAIN │ Earliest, most common symptom; severe, agonizing distal ache│
- │ │ Exacerbated by limb elevation; minimally responsive to meds │
- ├───────────────┼─────────────────────────────────────────────────────────────┤
- │ 2. PALLOR │ Waxy, cadaveric marble-white blanching; delayed refill │
- │ │ Fixed non-blanching violaceous mottling indicates necrosis │
- ├───────────────┼─────────────────────────────────────────────────────────────┤
- │ 3. POIKILO- │ Extremity becomes ice cold, equilibrating with room ambient │
- │ THERMIA │ temperature; sharp temperature demarcation one level below │
- ├───────────────┼─────────────────────────────────────────────────────────────┤
- │ 4. PULSELESS- │ Loss of palpable and handheld continuous-wave Doppler pulses│
- │ NESS │ Compare with contralateral limb; absent signal = occlusion │
- ├───────────────┼─────────────────────────────────────────────────────────────┤
- │ 5. PARESTHE- │ Earliest sensitive sign of nerve hypoxia; tingling, numbness│
- │ SIAS │ Reduced light touch and proprioception; heralds threat │
- ├───────────────┼─────────────────────────────────────────────────────────────┤
- │ 6. PARALYSIS │ LATE, OMINOUS SIGN; muscle weakness, foot drop, loss of toe │
- │ │ motion; heralds irreversible necrosis within 4 to 6 hours │
- └───────────────┴─────────────────────────────────────────────────────────────┘
Pain : The earliest and most frequent presenting symptom. Typically abrupt in onset, excruciating, sharp, and localized to the distal extremity (foot, toes, or calf). It is exacerbated by elevation and slightly relieved by hanging the foot in a dependent position. (Note: in advanced Category III ischemia or severe diabetic neuropathy, pain may paradoxically subside due to ischemic death of sensory nerve endings).
Pallor : Marked cutaneous blanching. In early ischemia, capillary refill is prolonged ( > 3 >3 > 3 to 5 seconds). With prolonged hypoperfusion, stagnant deoxygenated blood in dermal venules produces a mottled, cyanotic appearance. Fixed, non-blanching violaceous mottling ( livedo reticularis ) signifies microvascular thrombosis and irreversible tissue necrosis.
Poikilothermia (Coldness) : The limb loses thermoregulatory perfusion and equilibrates with the ambient room temperature, feeling "ice cold." A distinct, palpable line of temperature demarcation can often be appreciated, typically located one anatomic level distal to the point of arterial obstruction (e.g., common femoral artery occlusion causes coldness starting at the mid-to-lower thigh; popliteal artery occlusion produces coldness from the mid-calf down).
Pulselessness : Complete absence of palpable peripheral arterial pulses (femoral, popliteal, dorsalis pedis, posterior tibial) distal to the occlusion. Must always be verified and compared with the contralateral asymptomatic limb.
Paresthesias : Sensory deficit: tingling, prickling ("pins and needles"), hypoesthesia, and numbness. Sensory nerves are the first to fail under hypoxia; paresthesia is therefore the earliest and most sensitive physical sign of limb-threatening ischemia.
Paralysis : Motor deficit: weakness of toe flexion/extension, inability to dorsiflex the ankle (foot drop), and loss of intrinsic foot muscular function. Paralysis is an ominous, late finding signifying profound ischemia of large somatic motor nerve trunks and intrinsic skeletal muscle fibers. It demands emergent revascularization within hours to prevent permanent disability or amputation.
Etiological Classification: Arterial Embolism vs. In Situ Thrombosis
Identifying the underlying mechanism is essential because the surgical and endovascular management approaches diverge substantially:
Clinical Characteristic Arterial Embolism (~30–40%) In Situ Arterial Thrombosis (~50–60%)
Onset Sudden, dramatic, instantaneous (seconds to minutes) Insidious, gradual, stuttering progression over hours to days
Prior Claudication History Absent; normal baseline exercise tolerance Present; chronic history of exertional calf/thigh claudication
Pre-existing Collaterals Absent ; acute occlusion causes severe, profound ischemia Abundantly Present ; preexisting collaterals mitigate severity
Etiologic Sources Cardiac (~80%) : Atrial fibrillation, post-MI left ventricular mural thrombus, dilated cardiomyopathy, mechanical valves, infective endocarditis, atrial myxoma.; Non-Cardiac : Aortic/popliteal aneurysmal thrombi, ulcerated atherosclerotic plaque. Atherosclerotic plaque rupture, acute low-flow states (shock, dehydration, CHF), hypercoagulable states (HIT, APLS), peripheral bypass graft or stent thrombosis.
Common Anatomic Sites Arterial bifurcations with sudden vessel tapering:; • Common femoral bifurcation (~40%) ; • Aortic bifurcation (Saddle embolus); • Popliteal artery trifurcation Diffuse, diseased segments; superficial femoral artery at Hunter's adductor canal; bypass graft anastomoses.
Contralateral Limb Exam Normal ; palpable pulses, warm skin, normal baseline ABI Abnormal ; diminished or absent pulses, atrophic skin, hair loss, thickened nails, low ABI.
Angiographic Appearance Sharp, rounded "meniscus cutoff" or cup-shaped filling defect; vessel walls smooth with absent collaterals Diffuse irregular atherosclerotic disease, heavy calcification, extensive bridging collateral network.
Primary Revascularization Surgical Balloon Thromboembolectomy (Fogarty catheter) Catheter-Directed Thrombolysis (CDT), angioplasty/stenting, or surgical bypass grafting.
Bedside Diagnostic Evaluation
Handheld Continuous-Wave Doppler Ultrasound :
Indispensable extension of the physical examination. Evaluates both arterial and venous signals at the dorsalis pedis, posterior tibial, and popliteal levels.
Arterial Signal Characteristics : Normal peripheral arteries generate a triphasic waveform (systolic forward flow, early diastolic reversal, late diastolic forward flow) or biphasic waveform. In severe arterial occlusion, flow becomes monophasic (damped, low-resistance) or completely absent (inaudible).
Venous Doppler Audibility : Spontaneous, respiratory-phasic venous Doppler sounds confirm patent microvascular return. Inaudible venous flow indicates microvascular thrombosis, stagnant blood column, and advanced, irreversible ischemia.
Ankle-Brachial Index (ABI) :
Calculated by dividing the highest systolic ankle pressure (DP or PT) by the highest brachial systolic pressure. In acute limb ischemia, distal pressures are frequently unmeasurable or yield an ABI < 0.4 <0.4 < 0.4 , confirming critical hypoperfusion.
Urgent Vascular Imaging :
Diagnostic imaging must NEVER delay emergency operative revascularization in an immediately threatened limb (Rutherford Category IIb) .
Computed Tomographic Angiography (CTA) of the lower extremities with runoff: Modality of choice in viable or marginally threatened limbs. Fast, non-invasive, delineates the exact anatomical level of occlusion, status of distal runoff vessels, and presence of collaterals or aneurysms.
Catheter Digital Subtraction Angiography (DSA) : Gold standard; performed directly in the hybrid operating room or catheterization suite. Combines definitive diagnostic visualization with immediate endovascular intervention (thrombolysis, suction thrombectomy, angioplasty).
Laboratory Markers of Muscle Necrosis :
Serum Creatine Kinase (CK) : Direct quantitative marker of skeletal muscle cellular lysis. Surges with extensive rhabdomyolysis.
Serum Potassium & Chemistry Panel : Acute cellular ischemia leaks intracellular potassium; hyperkalemia must be identified and aggressively managed.
Urine Myoglobin : Detects myoglobinuria (tea-colored urine, urine dipstick positive for blood with few or no red blood cells on microscopic examination).
Serum Lactate : Evaluates systemic lactic acidosis and tissue hypoperfusion.
The Rutherford Classification of Acute Limb Ischemia
The Society for Vascular Surgery (SVS) Rutherford Clinical Classification stratifies acute limb ischemia into three operational categories that dictate urgency and modality of treatment:
Rutherford Category Viability Status Sensory Loss Muscle Weakness (Motor) Arterial Doppler Venous Doppler Clinical Management Strategy
Category I Viable ; (Not immediately threatened) None None Audible Audible Full-dose IV heparin; urgent CTA/DSA; semi-elective or urgent revascularization within 24 hours.
Category IIa Marginally Threatened ; (Salvageable if promptly treated) Minimal (confined to toes/digits) or none None Often Inaudible Audible Full-dose IV heparin; urgent imaging; catheter-directed thrombolysis (CDT) or surgical embolectomy within hours.
Category IIb Immediately Threatened ; (Salvageable with IMMEDIATE revascularization) Rest pain; extends beyond toes; mild/moderate numbness Mild to moderate weakness (toe movement, foot drop) Inaudible Audible EMERGENCY SURGICAL REVASCULARIZATION ; bypass extensive imaging; transport straight to hybrid OR for embolectomy/bypass.
Category III Irreversible ; (Permanent tissue loss inevitable) Profound, complete anesthesia Profound paralysis, rigor, fixed contracture, non-blanching mottling Inaudible Inaudible Revascularization CONTRAINDICATED ; emergent primary amputation to prevent fatal systemic reperfusion toxemia.
- Emergency Therapeutic Management & Revascularization
- 1. Immediate Systemic Heparinization
First-Line Medical Mandate : The very first intervention upon clinical diagnosis of ALI is the immediate administration of intravenous Unfractionated Heparin (UFH) .
Dosing : 80 units/kg IV bolus (maximum 5,000 units), followed by a continuous infusion of 18 units/kg/hour , targeting a therapeutic activated partial thromboplastin time (aPTT 1.5–2.5 times control) or anti-Xa level (0.3–0.7 IU/mL).
Mechanistic Rationale : Heparin does not dissolve the occluding thrombus; rather, it prevents thrombus propagation both proximally and distally, protects the patency of distal microvascular runoff beds, and prevents secondary thrombosis in stagnant venous beds.
2. Supportive Extremity Management
Positioning : Keep the affected extremity in a neutral or slightly dependent position (gravity encourages collateral arterial perfusion). NEVER ELEVATE THE LIMB , as elevation drops hydrostatic perfusion pressure and accelerates tissue ischemia.
Limb Protection : Protect the insensate limb with soft padding (e.g., heel protector boot, cotton wrapping). Avoid thermal trauma: never apply heating pads or ice packs , which cause catastrophic burns in ischemic, numb tissue.
Hydration : Aggressive intravenous isotonic crystalloid hydration to preserve renal tubular perfusion.
3. Revascularization Modalities
Surgical Balloon Thromboembolectomy (Fogarty Catheter) :
Procedure of choice for acute embolic occlusions and immediately threatened limbs (Rutherford Category IIb).
Performed under local or general anesthesia. Transverse arteriotomy (typically common femoral artery). A balloon-tipped Fogarty catheter is threaded beyond the occlusion, the balloon is gently inflated with saline, and the catheter is withdrawn, sweeping out the clot.
Catheter-Directed Thrombolysis (CDT) :
Local infusion of a fibrinolytic agent (recombinant tissue plasminogen activator, alteplase [tPA] ) directly into the thrombus via a multi-sidehole catheter embedded inside the clot. Infusion rate: 0.5 to 1.0 mg/hour of tPA over 12 to 24 hours.
Indicated for viable or marginally threatened extremities (Rutherford Category I and IIa) with thrombosed bypass grafts or extensive in situ atherosclerotic thrombosis, where an open surgical approach is technically challenging.
Percutaneous Mechanical Thrombectomy (PMT) :
Endovascular rheolytic, rotational, or suction aspiration thrombectomy devices that fragment and aspirate thrombus. Frequently combined with low-dose tPA (pharmacomechanical thrombectomy) to debulk clot rapidly and shorten infusion times.
Surgical Bypass Grafting / Endarterectomy :
Required when balloon embolectomy fails to restore adequate downstream flow, or when severe underlying atherosclerotic occlusive disease precludes simple embolectomy.
- Reperfusion Syndrome & Acute Compartment Syndrome
- 1. Post-Ischemic Reperfusion Syndrome
Restoring arterial blood flow to severely ischemic skeletal muscle triggers a paradoxical burst of cellular destruction mediated by reactive oxygen species (ROS), calcium overload, endothelial hyperpermeability, and complement activation. The washout of cellular breakdown products into the systemic circulation causes:
Hyperkalemia : Cellular lysis dumps massive intracellular potassium into the venous system, risking peaked T waves, conduction block, ventricular fibrillation, and sudden asystolic arrest immediately upon surgical arterial un-clamping.
Rhabdomyolysis & Acute Tubular Necrosis (ATN) : Massive myoglobin release precipitates in renal tubules with Tamm-Horsfall mucoprotein, particularly in acidic urine, causing direct tubular cytotoxicity and acute oliguric renal failure.
Severe Lactic Acidosis : Washout of anaerobic metabolites causes systemic vasodilation and myocardial depression.
Management : Vigorous IV crystalloid hydration ( 100 – 200 100–200 100–200 mL/h) to maintain high urine output ( ≥ 100 – 200 \ge 100–200 ≥ 100–200 mL/h), intravenous sodium bicarbonate to alkalinize the urine (target urine pH > 6.5 >6.5 > 6.5 ), continuous cardiac monitoring, and immediate treatment of hyperkalemia (calcium gluconate, insulin/dextrose, potassium binders).
2. Post-Reperfusion Acute Compartment Syndrome
Capillary leak and post-ischemic muscle edema within the rigid, unyielding osteofascial compartments of the leg (most commonly the anterior compartment ) cause interstitial pressure to exceed capillary perfusion pressure, obliterating microvascular blood flow.
Clinical Presentation :
Tense, hard, "wooden" swollen muscle compartments;
Severe pain out of proportion to exam, exquisitely aggravated by PASSIVE STRETCH of the muscles in the affected compartment (e.g., passive ankle plantarflexion stretches the anterior compartment muscles, triggering severe pain)—the single most sensitive early physical finding;
Paresthesias in the distribution of the nerve coursing through that compartment (e.g., deep peroneal nerve compression produces numbness in the first web space between the great and second toes);
Exam Pearl : Distal arterial pulses often remain palpable in early-to-moderate compartment syndrome because systolic blood pressure (120 mm Hg) exceeds intracompartmental pressure (35 mm Hg), even though microvascular capillary beds are completely collapsed!
Intracompartmental Pressure Measurement (Stryker Needle) :
Absolute intracompartmental pressure > 30 >30 > 30 mm Hg , or a Delta P ≤ 30 \le 30 ≤ 30 mm Hg (defined as Diastolic Blood Pressure − Intracompartmental Pressure \text{Diastolic Blood Pressure} - \text{Intracompartmental Pressure} Diastolic Blood Pressure − Intracompartmental Pressure ), establishes the diagnosis.
Definitive Treatment :
Emergent Surgical Four-Compartment Fasciotomy .
Decompresses all four lower leg compartments (anterior, lateral, superficial posterior, deep posterior) via two long longitudinal incisions (anterolateral and posteromedial).
Prophylactic fasciotomy should be performed concurrently during revascularization whenever ischemic time exceeds 4 to 6 hours.